Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Enterprise Value (EV)
- Capital Asset Pricing Model (CAPM)
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Accounts Payable
- Accounts payable exhibited fluctuations over the period, generally trending upward with some volatility. Starting at 347,800 thousand USD in March 2020, it increased to a peak of 789,500 thousand USD in December 2024 before slightly declining to 705,500 thousand USD by March 2025. Mid-period troughs occurred notably in September 2021 and September 2024.
- Accrued Expenses and Other Current Liabilities
- This category showed an overall increasing trend with significant variations. Beginning at 1,228,200 thousand USD in March 2020, it rose to 2,647,100 thousand USD by December 2023, followed by a modest decline to 2,241,800 thousand USD in March 2025. Some volatility was evident, with peaks around late 2023 and early 2024, suggesting variable operational or expense recognition timing.
- Debt and Finance Lease Liabilities
- Debt data appears sparse, with 1,500,000 thousand USD recorded only in June 2020. Finance lease liabilities had a current portion recorded mainly in late 2020 and early 2021, stabilizing around 719,000 thousand USD, while noncurrent portions were steady near 720,000 thousand USD throughout most of the periods, indicating stable finance lease commitments.
- Deferred Revenue
- Two lines of deferred revenue data are presented and appear to represent different classifications. The first generally showed fluctuations within a range of approximately 426,300 to 627,700 thousand USD, peaking in mid to late 2024. The second smaller deferred revenue line fluctuated between 27,000 and 211,800 thousand USD, showing an increasing trend from 2021 onwards, suggesting growing prepayments or obligations related to services or products delivered later.
- Current Liabilities
- Current liabilities showed variability, increasing sharply from 2,055,200 thousand USD in March 2020 to 3,932,500 thousand USD by December 2021, then fluctuating around 3,000,000 to 3,940,000 thousand USD up to March 2025. The fluctuations align with changes in accounts payable and accrued expenses, reflecting dynamic working capital management.
- Long-Term Debt
- Long-term debt appeared starting in September 2020 and steadily increased marginally from 1,978,300 thousand USD to 1,984,800 thousand USD by March 2025, indicating minimal new long-term borrowings or scheduled amortizations maintaining a nearly constant balance.
- Other Noncurrent Liabilities
- Other noncurrent liabilities increased notably from 772,000 thousand USD in March 2020 to 1,674,400 thousand USD by March 2025, with a significant rise beginning in 2023. This suggests growth in long-term obligations or provisions.
- Noncurrent Liabilities
- Noncurrent liabilities showed a substantial jump from 1,569,300 thousand USD in March 2020 to roughly 4,591,000 thousand USD by March 2025. A notable spike occurred between mid-2020 and September 2020, possibly related to the recognition of long-term debt or other obligations, followed by steady growth afterward.
- Total Liabilities
- Total liabilities increased from 3,624,500 thousand USD in March 2020 to a peak of over 8,405,800 thousand USD in December 2024, before a slight reduction to 8,157,600 thousand USD in March 2025. The rising trend reflects growing operational scale or financial leverage over the period, with notable expansions in both current and noncurrent liabilities.
- Common Stock and Capital Structure
- The common stock par value remained unchanged throughout, indicating no issuance or retirement of shares. Additional paid-in capital exhibited a strong upward trend from 5,211,400 thousand USD in March 2020 to 13,192,100 thousand USD in March 2025, signifying consistent equity financing or capital increases.
- Retained Earnings
- Retained earnings steadily increased from 8,004,400 thousand USD in March 2020 to 32,384,400 thousand USD by March 2025, reflecting sustained profitability and accumulation of earnings without significant dividend distributions or losses.
- Accumulated Other Comprehensive Income (Loss)
- This item showed volatility and oscillated between positive and negative values. Notably, it began slightly negative, moved into positive territory mid-period, dipped sharply negative around 2022, and returned toward a small positive by March 2025. This pattern indicates exposure to variable market elements such as foreign currency translation or investment valuation adjustments.
- Treasury Stock
- Treasury stock at cost increased in absolute value from -1,073,800 thousand USD in March 2020 to -16,218,100 thousand USD by March 2025, indicating substantial repurchase of company shares over time, which reflects a significant capital allocation toward buybacks.
- Stockholders' Equity
- Stockholders' equity initially dropped from 12,133,000 thousand USD in March 2020 to 9,057,400 thousand USD in June 2020, potentially due to share repurchases or valuation changes, then consistently increased thereafter, reaching 29,387,600 thousand USD by March 2025. This increase aligns with rising retained earnings and paid-in capital, demonstrating growth in net asset value despite the negative impact of treasury stock.
- Total Liabilities and Stockholders’ Equity
- The combined total increased from 15,757,500 thousand USD in March 2020 to a peak of 37,759,400 thousand USD in December 2024, with a slight decline to 37,545,200 thousand USD by March 2025. The growth is largely driven by increases in both liabilities and equity components, reflecting the expanding scale of the entity's financial base.